Johnson & Johnson and TIME have launched the Healthcare Champion of the Year award to recognize healthcare professionals in the United States. The new branded award aims to honor individuals whose care, innovation, and grit are driving health system change to advance better care for all. The honoree will be announced leading up to TIME’s "A Year in TIME" celebration on December 9, 2026, in New York City.

Nominations for the inaugural award will open on July 16, 2026, and close at 5:00 p.m. ET on August 28, 2026. The winner will be selected by Johnson & Johnson and a panel of industry experts. Eligible nominees include physicians, nurses, advanced practice clinicians, surgeons, community health workers, care navigators, and other healthcare professionals actively involved in clinical care or care delivery in the United States.

Recognizing Healthcare Leaders

The award seeks to spotlight healthcare leaders who are strengthening care amid growing pressure on health systems. Nominees may be at any stage of their career and should demonstrate real-world impact by how they show up for patients, colleagues, and communities. Nominations should reflect at least one of the program’s core themes: grit, innovation, or patient care.

Commitment to Health Workforce

The recognition builds on Johnson & Johnson’s long-standing commitment to improving health outcomes by championing nursing and a thriving health workforce. Through J&J CareCommunity, the company’s global social impact platform, Johnson & Johnson helps equip nurses and community health workers with the skills, resources, and connections they need to strengthen health systems and expand access to care.

Nomination Timeline

Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs at Johnson & Johnson, said the award recognizes those whose compassion, innovation, and grit are transforming patient care today and building a healthier tomorrow.

Johnson & Johnson has declared a cash dividend of $1.34 per share on its common stock for the third quarter of 2026. The dividend is payable on September 8, 2026 to shareholders of record at the close of business on August 25, 2026. The ex-dividend date is August 25, 2026.

Dividend Details

The Board of Directors of Johnson & Johnson approved the dividend, maintaining the company's commitment to returning value to shareholders. The payment will be made to investors who hold the stock at the close of business on the record date.

About Johnson & Johnson

Johnson & Johnson operates in Innovative Medicine and MedTech sectors. The company focuses on healthcare innovation to prevent, treat, and cure complex diseases.